Company Encyclopedia
View More
name
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS.US
News
View More

Ondas Holdings Announces $5.2 Million Debt Exchange and Expects $60.5 Million Non-Cash Charge

Ondas Holdings Inc. announced a $5.2 million debt exchange involving convertible promissory notes and warrants issued by its subsidiary, Ondas Autonomous Systems Inc. The exchange allows conversion into common stock, expecting to issue 6.9 to 7.3 million new shares and record a non-cash charge of $56.6 to $60.5 million in Q4 2025. Definitive agreements are anticipated by December 15, 2025.

Reuters·
US
ONDS
-2.99%
Reuters·
US
ONDS
-2.99%

Ondas Holdings Director Ron Stern Resigns

Ondas Holdings Inc. announced the resignation of Ron Stern from his position as director and all other roles within the company and its subsidiaries, effective December 12, 2025.

Reuters·
US
ONDS
-2.99%
Reuters·
US
ONDS
-2.99%

10 Industrials Stocks With Whale Alerts In Today's Session

Today's session saw significant options activity involving 10 industrial stocks. Notable trades include bearish put sweeps for CAT, UBER, and GEV, and bullish call sweeps for PL and RKLB. UPS showed bullish sentiment with a put trade, while TPC had a bearish call sweep. VRT's put sweep was neutral, and NNE's put sweep was bullish. These activities indicate potential trading opportunities.

benzinga_article·
US
TPC
-4.43%
US
UBER
-0.39%
US
CAT
-4.43%
benzinga_article·
US
TPC
-4.43%
US
UBER
-0.39%
US
CAT
-4.43%

Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $57.00

Citizens Jmp raised Terns Pharmaceuticals' price target from $35.00 to $57.00, giving it a "market outperform" rating. Other firms also increased their targets, with Truist Financial, Mizuho, HC Wainwright, and Barclays boosting their price objectives. The stock opened at $44.61 on Thursday, with a market cap of $4.02 billion. Analysts expect Terns Pharmaceuticals to post -1.19 EPS for the year. Institutional investors own 98.26% of the stock.

Market Beat·
US
TERN
-4.44%
Market Beat·
US
TERN
-4.44%

Terns Pharmaceuticals, Inc. Announces Upsized Public Offering

Terns Pharmaceuticals, Inc. announced an upsized public offering on December 9, 2025, aiming to raise $705.8 million. The offering includes 16,250,000 shares at $40 each, with underwriters exercising an option for 2,437,500 additional shares. Net proceeds are estimated at $705.8 million, intended to support TERN-701 development and corporate needs, with cash expected to fund operations into 2031.

TradingView·
US
TERN
-4.44%
TradingView·
US
TERN
-4.44%
© 2025 Longbridge｜Disclaimer